Gujarat Magazine

Creative Biolabs: New Scientific Tools for Advancing Neurology Research

 Breaking News
  • No posts were found

Creative Biolabs: New Scientific Tools for Advancing Neurology Research

March 12
18:12 2024
A new array of cutting-edge research tools has recently debuted at Creative Biolabs, poised to propel the development of therapies for neurological diseases.

New York, USA – March 12, 2024 – From Alzheimer’s to Parkinson’s, neurological diseases present formidable hurdles to global public health. Despite concerted research endeavors, effective treatments for many of these conditions remain elusive. Acknowledging this pressing need for innovative research tools, Creative Biolabs has introduced novel resources essential for unraveling the complexities of neurological disorders.

“One crucial player in the puzzle of neurological diseases is Complement Factor H (CFH), a pivotal regulator of the complement system vital for maintaining immune balance. Dysregulation of CFH has been implicated in various neurological disorders, including age-related macular degeneration and Alzheimer’s disease (AD),” stated a researcher at Creative Biolabs.

The company now offers a comprehensive suite of CFH-related products, including recombinant proteins and antibodies, empowering researchers to delve into CFH’s role in disease mechanisms and explore its therapeutic promise.

“Recent investigations highlight CR3’s involvement in the pathogenesis of Alzheimer’s disease. Microglial CR3 appears to influence soluble ß-amyloid (Aß) clearance, independent of phagocytosis,” emphasized the researcher. “This sheds new light on the immune aspects of neurodegenerative diseases.”

Creative Biolabs delivers top-tier antibodies and inhibitors targeting the CR3 receptor, facilitating the study of microglial activation and its impact on disease progression.

Furthermore, Creative Biolabs offers an extensive array of authenticated neuron cell lines derived from various species and custom mini brain organoid models tailored to specific research needs, including disease modeling and drug screening.

A full range of high-quality neural cell line products, including but not limited to:

* Neural stem cell lines

* Neural progenitor cell lines

* Primary neurons

* Neuroglial cell lines

* Astrocyte cell lines

* Microglial cell lines

* Oligodendroglia cell lines

These cell lines and advanced platforms provide unprecedented insights into disease mechanisms and facilitate the identification of novel therapeutic targets.

“We’re thrilled to unveil our latest innovations aimed at advancing therapy development for neurological diseases,” expressed a spokesperson for Creative Biolabs. “By offering state-of-the-art research tools and services, we empower scientists worldwide to drive groundbreaking discoveries, ultimately promoting the discovery of effective treatments for neurological disorders.”

For further details about Creative Biolabs and its products for neurology research, please visit https://neuros.creative-biolabs.com.

About Creative Biolabs

With decades of involvement in neuroscience research, Creative Biolabs provides an extensive range of pioneering research tools and services to help researchers overcome scientific obstacles. Committed to excellence and customer satisfaction, the company strives to accelerate scientific progress and improve human health through advanced biotechnology.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://neuros.creative-biolabs.com